Detalles de la búsqueda
1.
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis).
Dermatol Ther (Heidelb)
; 14(6): 1649-1657, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38748344
2.
Bimekizumab for the Treatment of Plaque Psoriasis with Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis).
Dermatol Pract Concept
; 14(2)2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38416060
3.
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis).
J Dermatolog Treat
; 35(1): 2350760, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38714323
4.
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis).
Front Immunol
; 14: 1341708, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38274801
5.
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study-IL PSO (Italian landscape psoriasis).
Front Med (Lausanne)
; 10: 1243843, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37614958
6.
Malignant fibrous histiocytoma of the skin: a case treated with radiotherapy.
G Ital Dermatol Venereol
; 151(3): 323-5, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27176091
Resultados
1 -
6
de 6
1
Próxima >
>>